Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

GSTS Celebrate Success of Inaugural Scientific Symposium and Launch Innovation Academy

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
GSTS recently hosted their first Innovation Academy event in London (28 June 2013).

This inaugural scientific symposium welcomed over 100 attendees, offering participants great networking opportunities and the chance to hear presentations from a group of GSTS experts.

Discussions were focused into four tracks – child health, keeping people healthy, infectious diseases, and next-generation diagnostics – and on-show was the innovative approach to laboratory medicine that can be found throughout the GSTS organisation.

GSTS_Photo.gifDr Dominic Harrington, Scientific Director, and co-chair of the event, said, “Clinical science is part of the fabric of GSTS, and the scientists presenting here today continue to make significant contributions to the further development of best-practice in clinical pathology. The Innovation Academy event allowed us to share, celebrate and support the contributions of our staff. We were delighted to see the turnout on the day and look forward to the next one.”

As the UK's leading independent provider of pathology services, GSTS and King's College Pathology LLP provide pathology services that make a real difference to patient care. The Innovation Academy was organised to create an environment to support innovation, quality and the development of future scientific leaders. Dr Harrington said “Today is about the scientists being heard. We have broken the science into four broad themes to help make potentially higher level science more accessible to the decision makers and executive teams, as well as for our users. This enables us to articulate the value that scientists bring to patients, medics, and to the GSTS organisation.”

Drawing from twelve senior scientists across the GSTS and KingsPath partnership, the presentations covered current trends and topical developments in areas such as expanded newborn screening, vitamin B12 deficiency, HIV drug resistance and pre-implantation genetic diagnosis. Dr Harrington said “Underneath today’s themes is some real high end science and this has come across because, after all, a subject matter expert is always the best person to articulate the enthusiasm for that area”.

Dr Harrington added, “There is currently a direction towards consolidation of laboratory services and this is a challenge, so having an event such as this where the collaboration can come together really helps partners learn and understand each others’ expertise.

The next event in the series is planned for 6th December 2013.

To find out more about innovation at GSTS and KingsPath, please visit:

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos